Influenza Market Global Scenario, Market Size, Outlook, Trend, and Forecast, 2016 – 2025

Influenza Market Global Scenario, Market Size, Outlook, Trend, and Forecast, 2016 – 2025

Report Description

The Global Influenza Marketis expected to grow at CAGR of 3.4% from 2017 to 2025. The report highlights the key trends, market outlook and the global scenario of the Global Influenza Market. The market sizing is provided from 2016 to 2025, wherein the forecast is provided from 2017 to 2025. In addition, market dynamics (i.e. market drivers, market restraints and market opportunities) which covers factors supporting the market growth, factors restraining the market growth and factors behind the opportunities across this industry in the coming years has been included extensively under the scope of the study. The report also provides extensive detail of the market segments across type, application, and geography; market share of the key players globally and the competitive scenario throughout the forecast period, industry expert opinion, and profiles of the key players in the market. The major key players of the market are as follows:

KEY PLAYERS

ALVOGEN

ABBOTT LABORATORIES

CHIRON CORPORATION

CSL LIMITED

DAIICHI SANKYO CO. LTD.

MITSUBISHI TANABE PHARMA CORPORATION

NANOTHERAPEUTICS INC.

ROCHE HOLDING AG

SHIONOGI & CO. LTD.

SINOVAC BIOTECH LTD.

ASTRAZENECA

BIOCRYST PHARMACEUTICALS.INC.

CSL LIMITED

EMERGENT BIOSOLUTIONS

GLAXOSMITHKLINE

PROTEIN SCIENCES CORPORATION

SANOFI PASTEUR, INC.

SERUM INSTITUTE OF INDIA PVT.LTD.

Scope of the Market

VaccineMarket

Trivalent

Quadrivalent

End-UserMarket

Children and Adolescent

Adult

Elderly

Geography Market

North America

Europe

Asia Pacific

Rest of the World (RoW)

Back to top

Payment Options

Single User : $3,897
Five User: $5,175
Enterprise : $9,175